Commonwealth Equity Services, LLC Pds Biotechnology Corp Transaction History
Commonwealth Equity Services, LLC
- $66 Billion
- Q3 2024
A detailed history of Commonwealth Equity Services, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 78,397 shares of PDSB stock, worth $117,595. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78,397
Previous 78,927
0.67%
Holding current value
$117,595
Previous $231,000
29.44%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PDSB
# of Institutions
64Shares Held
4.05MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$2.28 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$730,4500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$622,6690.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$351,3130.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA134KShares$201,3900.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $42.7M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...